Symbicort Rapihaler 50/3 TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: budesonide + eformoterol
Brand name
(ARTG)
: SYMBICORT RAPIHALER budesonide / formoterol fumarate dihydrate 50/3 pressurised metered dose inhalerDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Asthma Symbicort Rapihaler is indicated in adults and adolescents (12 years and older), for the treatment of asthma to achieve overall asthma control, including the relief of symptoms and the reduction of the risk of exacerbations (see Section 4.2 Dose and method of administration). Chronic obstructive pulmonary disease (COPD) Symbicort 200/6 is indicated for the symptomatic treatment of moderate to severe COPD (FEV1 < or = 50% predicted normal) in adults with frequent symptoms despite long-acting bronchodilator use, and/or a history of recurrent exacerbations. Symbicort is not indicated for the initiation of bronchodilator therapy in COPD.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Inhalation, pressurised
- Inhalation
- Contents held in metal can fitted with plastic valve. After evaporation of the propellant a residue remains which is free from visible contaminants. The external & internal can and valve surfaces are free from corrosion and significant defects.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Shelf lifetime is 12 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 120 doses pack
- 2 x 120-dose inhalers pack
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
